Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Identification of genetic alterations of AXIN2 gene in adrenocortical tumors.

Chapman A, Durand J, Ouadi L, Bourdeau I.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1477-81. doi: 10.1210/jc.2010-2987. Epub 2011 Jul 6.

PMID:
21733995
2.

AXIN genetic analysis in adrenocortical carcinomas updated.

Guimier A, Ragazzon B, Assié G, Tissier F, Dousset B, Bertherat J, Gaujoux S.

J Endocrinol Invest. 2013 Dec;36(11):1000-3. doi: 10.3275/9022. Epub 2013 Jul 1.

PMID:
23812285
3.

Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.

Durand J, Lampron A, Mazzuco TL, Chapman A, Bourdeau I.

J Clin Endocrinol Metab. 2011 Jul;96(7):E1206-11. doi: 10.1210/jc.2010-2143. Epub 2011 May 11.

PMID:
21565795
4.

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.

Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J.

J Clin Endocrinol Metab. 2008 Oct;93(10):4135-40. doi: 10.1210/jc.2008-0631. Epub 2008 Jul 22.

PMID:
18647815
5.

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.

Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B, Libé R, René-Corail F, Audebourg A, Vacher-Lavenu MC, Groussin L, Bertagna X, Dousset B, Bertherat J, Tissier F.

J Clin Endocrinol Metab. 2011 Feb;96(2):E419-26. doi: 10.1210/jc.2010-1885. Epub 2010 Nov 17.

PMID:
21084400
6.

Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.

Tadjine M, Lampron A, Ouadi L, Bourdeau I.

Clin Endocrinol (Oxf). 2008 Feb;68(2):264-70. Epub 2007 Sep 14.

PMID:
17854394
7.

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.

Cancer Res. 2005 Sep 1;65(17):7622-7.

8.

Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.

Gaujoux S, Hantel C, Launay P, Bonnet S, Perlemoine K, Lefèvre L, Guillaud-Bataille M, Beuschlein F, Tissier F, Bertherat J, Rizk-Rabin M, Ragazzon B.

PLoS One. 2013;8(2):e55743. doi: 10.1371/journal.pone.0055743. Epub 2013 Feb 7.

9.

Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).

Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.

Clin Endocrinol (Oxf). 2008 Sep;69(3):367-73. doi: 10.1111/j.1365-2265.2008.03273.x. Epub 2008 Apr 14.

10.

Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.

Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M, Antonini SR.

J Clin Endocrinol Metab. 2011 Oct;96(10):3106-14. doi: 10.1210/jc.2011-0363. Epub 2011 Aug 17.

PMID:
21849527
11.

Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.

Castiglia D, Bernardini S, Alvino E, Pagani E, De Luca N, Falcinelli S, Pacchiarotti A, Bonmassar E, Zambruno G, D'Atri S.

Genes Chromosomes Cancer. 2008 Jul;47(7):614-24. doi: 10.1002/gcc.20567.

PMID:
18384130
12.

Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.

Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, Meatchi T, Libé R, Bertagna X, Audebourg A, Zucman-Rossi J, Tissier F, Bertherat J.

Clin Cancer Res. 2010 Nov 1;16(21):5133-41. doi: 10.1158/1078-0432.CCR-10-1497. Epub 2010 Oct 26.

13.

Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.

Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S.

Hum Pathol. 2013 Nov;44(11):2438-48. doi: 10.1016/j.humpath.2013.06.002. Epub 2013 Sep 5.

PMID:
24011952
14.

Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.

Ronchi CL, Sbiera S, Leich E, Tissier F, Steinhauer S, Deutschbein T, Fassnacht M, Allolio B.

J Clin Endocrinol Metab. 2012 Dec;97(12):E2251-60. doi: 10.1210/jc.2012-2669. Epub 2012 Oct 9.

15.

Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.

Pusantisampan T, Sangkhathat S, Kayasut K, Kanngurn S, Jaruratanasirikul S, Chotsampancharoen T, Kritsaneepaiboon S.

Pediatr Dev Pathol. 2010 May-Jun;13(3):238-42. doi: 10.2350/09-07-0683-CR.1.

PMID:
19863445
16.

Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.

Huang SC, Ng KF, Yeh TS, Chang HC, Su CY, Chen TC.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S438-46. doi: 10.1245/s10434-011-1930-x. Epub 2011 Jul 19.

PMID:
21769465
17.

Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.

Rubin B, Regazzo D, Redaelli M, Mucignat C, Citton M, Iacobone M, Scaroni C, Betterle C, Mantero F, Fassina A, Pezzani R, Boscaro M.

Tumour Biol. 2016 Oct;37(10):13545-13555. Epub 2016 Jul 28.

PMID:
27468715
18.

Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.

Koch A, Hrychyk A, Hartmann W, Waha A, Mikeska T, Waha A, Schüller U, Sörensen N, Berthold F, Goodyer CG, Wiestler OD, Birchmeier W, Behrens J, Pietsch T.

Int J Cancer. 2007 Jul 15;121(2):284-91.

19.

AXIN2 Polymorphisms, the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility.

Aristizabal-Pachon AF, Carvalho TI, Carrara HH, Andrade J, Takahashi CS.

Asian Pac J Cancer Prev. 2015;16(16):7277-84.

20.

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.

Mitsui Y, Yasumoto H, Nagami T, Hiraki M, Arichi N, Ishikawa N, Araki A, Maruyama R, Tanaka Y, Dahiya R, Shiina H.

Oncotarget. 2014 Apr 30;5(8):2198-207.

Supplemental Content

Support Center